Bruce Wendel

Insider Reports History

Location
San Diego, CA
Signature
/s/ Philip LoScalzo, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bruce Wendel:

Company Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. Director Option to purchase Common Stock 500,000 27 Jan 2023 Direct
ImmunityBio, Inc. Director Stock Option (right to buy) 146,020 12 Dec 2025 Direct

Insider Reports Filed by Bruce Wendel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IBRX ImmunityBio, Inc. 12 Dec 2025 1 $0 4 Director 16 Dec 2025, 17:55
IBRX ImmunityBio, Inc. 12 Dec 2025 0 $0 3 Director 16 Dec 2025, 17:54
GTBP GT Biopharma, Inc. 27 Jan 2023 1 $0 4 Director 01 Feb 2023, 05:01
GTBP GT Biopharma, Inc. 15 Jul 2022 2 $0 4 Director 19 Jul 2022, 21:42
GTBP GT Biopharma, Inc. 16 Nov 2020 5 +$26,299 4 Director 07 Oct 2021, 14:47
GTBP GT Biopharma, Inc. 11 Nov 2020 0 $0 3 Director 07 Oct 2021, 14:40